Health Care
Viewpoints
Filter by:
CMS Abandons Certain Controversial Provisions in its Proposed Medicare Part D Rule
March 10, 2014 | Blog | By Theresa Carnegie
Following an onslaught of criticism, CMS told Congress today that it will not move forward with certain controversial provisions of its proposed rule on the Medicare Advantage and Medicare Part D prescription drug program.
Read more
Avoid the Anti-Corruption “Blacklist:” Chinese Agency Guidance
March 5, 2014 | Blog
On March 1, 2014, Circular No. 50, which the Chinese National Health and Family Planning Commission (NHFPC) recently promulgated to regulate the conduct of pharmaceutical and medical device companies that do business in China, went into effect.
Read more
Unprecedented HIPAA Fine May Mean Increased Scrutiny and Penalties
February 26, 2014 | Blog | By Kimberly Gold
Triple-S Management Corp. (“Triple-S”), a Puerto Rico-based health insurer, has been fined $6.8 million by the Puerto Rico Health Insurance Administration (“PRHIA”) following a Health Insurance Portability and Accountability Act ("HIPAA") breach by its subsidiary, Triple-S Salud Inc. (“TSS”), involving more than 13,000 beneficiaries.
Read more
ML Strategies Posts Weekly Health Care Reform Update on February 24, 2014
February 26, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
Read more
En Español: HHS Agencies Issue Model Notices of Privacy Practices in Spanish
February 24, 2014 | Blog
Last week, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) and Office for the National Coordinator for Health Information Technology (ONC) issued model Notices of Privacy Practices (NPPs) in Spanish.
Read more
A Guide to the FDA's Proposed Social Media Guidance
February 23, 2014 | Blog | By Kimberly Gold
The FDA recently proposed guidance for the submission of materials disseminated through real-time social media promotions ("Interactive Promotional Media") for postmarketing reporting purposes.
Read more
Notice to Plans and PBMs: Pay for Contraceptive Services and Maybe We Will Pay You Back
February 18, 2014 | Blog | By Theresa Carnegie
As has been widely covered in the news, regulations and guidance developed under the Affordable Care Act (“ACA”) require that non-grandfathered health plans make preventive care and screenings available to their members at no cost (i.e. no deductibles, coinsurance, or co-payments).
Read more
CMS Expands Payment Reform to Outpatient Care in New RFI
February 12, 2014 | Blog
Citing the need to complement a portfolio of pilot projects that focus mostly on primary care and the inpatient setting, CMS released a Request for Information (RFI) on February 11th, seeking input on potential payment and care delivery models that focus on outpatient specialty care and complex/chronic disease management care.
Read more
OIG Plans to Fight Fraud, Waste, and Abuse While Promoting Quality, Safety, and Value in 2014
February 12, 2014 | Blog | By Theresa Carnegie
The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) released its Work Plan for Fiscal Year 2014 on January 31, 2014. The Work Plan provides insight into the OIG’s priorities by providing a brief description of the activities it will initiate and continue during fiscal year 2014.
Read more
HHS-OIG Criticizes 340B Drug Discount Program
February 11, 2014 | Blog | By Theresa Carnegie
I recently posted that 2014 is expected to be a year of major developments in the 340B Drug Discount Program, with HRSA receiving enhanced funding, stepping up audit activity, and drafting regulations in response to criticism from multiple industry stakeholders.
Read more
More Open Questions About Open Payments Under the Sunshine Act
February 10, 2014 | Blog | By Brian Dunphy
Last week, the Centers for Medicare & Medicaid Services (“CMS”) clouded the process for pharmaceutical and medical device manufacturers, and group purchasing organizations (“GPOs”), to register and submit reports under the Physician Payments Sunshine Act (the “Act”).
Read more
ML Strategies Posts Weekly Health Care Reform Update on February 3, 2014
February 6, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
Read more
CMS Finalizes HIPAA and CLIA Amendments Intended to Increase Patient Access to Test Results
February 4, 2014 | Blog | By Karen Lovitch
Yesterday the Centers for Medicare & Medicaid Services (CMS) finally published the long-awaited final rule amending the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to permit CLIA-certified laboratories to provide copies of completed test reports to patients upon request.
Read more
ACOs Show Some Savings Potential: Legislative and Regulatory Initiatives Ramping Up
February 4, 2014 | Blog
The evolution of Accountable Care Organizations (ACOs) will be a big factor this year as the Obama Administration continues to focus on curbing health care spending and Congress ramps up its efforts to address physician payment and delivery system reform.
Read more
OIG Issues Favorable Opinion of Arrangement Containing Percentage-Based Compensation Structure
February 3, 2014 | Blog | By Roy Albert
Last week, the OIG issued an advisory opinion indicating that it would not impose sanctions on an arrangement pursuant to which a placement agency receives a percentage-based fee for referring new residents to senior communities.
Read more
Health Care Reform Goals Fail to Persuade Court in Antitrust Challenge to Acquisition
February 3, 2014 | Blog
On January 24, 2014, a federal district court judge validated the trend of recent increased Federal Trade Commission (FTC) scrutiny of physician practice consolidations and acquisitions by upholding the agency’s antitrust challenge to the St. Luke’s Health System (St. Luke’s) 2012 acquisition of Saltzer Medical Group (Saltzer).
Read more
2014 May Be a Game-Changer for the 340B Drug Discount Program
January 29, 2014 | Blog | By Theresa Carnegie
The year 2014 looks to be a year of major developments for the 340B Drug Discount Program.
Read more
Record Numbers for Medicare Fraud Task Force Prosecutions in 2013
January 29, 2014 | Blog | By Theresa Carnegie
On January 27, 2014, the U.S. Department of Justice issued a press release announcing that its Medicare Fraud Task Force had “set record numbers for health care prosecutions in Fiscal Year 2013.”
Read more
ML Strategies Posts Weekly Health Care Reform Update on January 27, 2014
January 28, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
Read more
Government Imposes Moratorium on Medicare Hearings and Appeals
January 27, 2014 | Blog | By Theresa Carnegie
The Federal Office of Medicare Hearings and Appeals (OMHA) was established in July 2005 to administer the Medicare appeals program. OMHA adjudicates appeals regarding Medicare entitlement and Medicare provider reimbursement.
Read more
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology